伴随"健康中国2030"规划纲要深入实施，大健康产业正成为推动经济高质量发展的重要引擎。近日党的二十届四中全会审议通过的"十五五"规划建议作 出"实施健康优先发展战略"重要部署，将提高人均预期寿命和人民健康水平作为健康中国建设的重要目标。 在这一战略指引下，健康产业创新成为落实部署的关键抓手，而农业与生物科技的深度融合则为大健康产业发展提供了全新思路。2025年12月10 日，"服务健康中国战略 促进产业创新发展"主题座谈会在新华社国家金融信息大厦举办，旨在推动政、产、金、学、研、媒协同发力，共同探讨健康产业 高质量发展新路径。 本次座谈会期间，新华网上市公司研究院与三主粮集团签署合作协议，双方将围绕加快建设健康中国开展深度合作，推动中国农业创新与生物科技深度 融合，通过构建"媒体+智库+产业"协同机制，开展健康知识传播、科技成果转化等务实探索。 《委员会 内蒙 证书号:2024-J-1-04-D7 "在粮食安全的版图上，小麦与水稻长期占据核心地位。但在中国北疆的广袤土地上，更具健康功能性价值的燕麦将改写传统主粮格局。"三主粮集团创 始人孙治介绍称，燕麦是九种粮食当中唯一的功能性食品，是提高人体免疫力的首选食 ...

Core Insights - Minsheng Health reported a revenue of 641 million yuan for 2024, representing a year-on-year growth of 10.23% [1] - The company achieved a net profit attributable to shareholders of 91.83 million yuan, up 7.24% year-on-year [1] - Basic earnings per share stood at 0.26 yuan [1] Financial Performance - Gross margin for 2024 was 55.77%, a decrease of 6.30 percentage points year-on-year [3] - Net profit margin was 14.32%, a slight decline of 0.40 percentage points year-on-year [3] - Sales expenses amounted to 191 million yuan, an increase of 0.32% year-on-year, primarily for channel maintenance and brand promotion [3] - Research and development expenses were 23.98 million yuan, down 18.87% year-on-year, accounting for 3.74% of revenue [3] Cash Flow Analysis - Net cash flow from operating activities was 108 million yuan, a slight increase of 0.28% year-on-year, indicating stable operating cash collection ability [3] - Net cash outflow from investing activities was 280 million yuan, an increase of 45.53% year-on-year, mainly for fundraising projects and financial product purchases [3] - Net cash flow from financing activities was -38.34 million yuan, a decline of 104% year-on-year [3] Business Segmentation - Revenue from vitamins and minerals reached 621 million yuan, growing 10.47% year-on-year, accounting for 96.91% of total revenue [3] - Revenue from other health products was 12 million yuan, up 8.01% year-on-year, representing 1.93% of total revenue [3] - Probiotic revenue was 4.22 million yuan, down 33.74% year-on-year, making up 0.66% of total revenue [3] Research and Development - The company obtained 3 new authorized invention patents and completed the development of 5 functional food products in 2024 [3] - Ongoing research pipelines include Minoxidil lotion (for hair growth) and traditional Chinese medicine products, with future plans to expand into sleep health and sports nutrition sectors [3]